COSCIA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 188
NA - Nord America 108
AS - Asia 29
Totale 325
Nazione #
US - Stati Uniti d'America 108
IE - Irlanda 96
SE - Svezia 46
DE - Germania 22
HK - Hong Kong 18
IT - Italia 11
SG - Singapore 9
UA - Ucraina 6
CZ - Repubblica Ceca 5
FR - Francia 2
IN - India 1
IR - Iran 1
Totale 325
Città #
Dublin 96
Hong Kong 18
Chandler 15
Bremen 12
Lawrence 12
Princeton 12
Boardman 11
Jacksonville 10
Singapore 6
Brno 5
Somaglia 4
Munich 3
Piemonte 3
Gunzenhausen 2
San Mateo 2
Arona 1
Cagliari 1
Grafing 1
Naples 1
Palermo 1
Wilmington 1
Zanjan 1
Totale 218
Nome #
Prognostic significance of PET/CT in patients with chronic lymphocytic leukemia (CLL) treated with frontline chemoimmunotherapy 38
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study 34
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter’s syndrome: therapeutic implications 33
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 32
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 29
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group 26
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib 26
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 25
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 24
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study 24
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 24
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 23
Totale 338
Categoria #
all - tutte 2.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 2 0 1 3 1 0
2020/202116 1 0 1 0 3 2 3 0 3 0 3 0
2021/202241 0 0 2 1 1 0 1 1 1 1 11 22
2022/2023203 12 10 20 0 13 13 1 20 101 1 5 7
2023/202468 5 6 6 1 8 0 18 0 0 0 3 21
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 338